Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

Lower expense ratio.

Lower expense ratio.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons

-

-

INDMoney rank
5/8
1/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 9 Months

7 Years 8 Months

Fund AUM

₹2812 Cr

₹6456 Cr

Min Investment
  1. SIP ₹99
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.48%

1.02%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

35

42

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.06%)
  2. Divi's Laboratories Ltd(8.56%)
  3. Glenmark Pharmaceuticals Ltd(6.51%)
  4. Apollo Hospitals Enterprise Ltd(5.95%)
  5. Cipla Ltd(5.54%)
  1. Sun Pharmaceuticals Industries Ltd(12.05%)
  2. Cipla Ltd(7.9%)
  3. Dr Reddy's Laboratories Ltd(7.82%)
  4. Divi's Laboratories Ltd(7.1%)
  5. Mankind Pharma Ltd(6.44%)
No of Sectors

2

2

Top 3 Sectors
  1. Health(98.78%)
  2. Basic Materials(1.22%)
  1. Health(98.89%)
  2. Basic Materials(1.11%)
Equity %

99.46%

97.87%

Debt %

-

-

P/E

39.02

30.85

P/B

5.45

4.3

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-3.49%

-4.26%

3-Month Return

-5%

-6%

6-Month Return

-3.41%

-3.84%

1-Year Return

3.5%

4.26%

3-Year Return

23.42%

28.41%

5-Year Return

16.42%

17.8%

Sharpe

0.92

1.19

Alpha

-0.59

3.82

Beta

0.98

0.95

Standard Deviation

16.5

16.02

Information Ratio

-0.34

1.23

Description

Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Vrijesh Kasera

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons